Oridion signs distributor pact with IMI expanding its presence in Japanese market
Oridion , creator of the Smart Capnography family of algorithm-based solutions (Integrated Pulmonary Index, SARA, and Smart Breath Detection Algorithm) announced the signing of a new agreement with IMI Co. Ltd. a leading distributor of medical equipment in Japan. This agreement provides Oridion with the opportunity to further expand into the Japanese market with its line of Microstream capnography monitoring products.
IMI will bundle sales of Capnostream20 Smart Capnography monitors including IPI with their ventilators. This powerful combination will be offered as SafetySet, an innovative solution to improve patient safety and make a clinical difference in patient care. IMI will begin selling the Capnostream20 monitors and patented FilterLine etCO2 sampling products immediately into the Critical Care environment and Home Care areas throughout Japan.
Kazumasa Tsumuga, president of IMI said: “We are happy to join with Oridion to make available the best capnography technology to our hospital markets in Japan. We believe the collaboration between IMI and Oridion will help improve the safety for all the patient populations in all clinical settings in Japan.”
Gerry Feldman, president of Oridion Capnography Inc. remarks, “We are honoured to be working with IMI. The SafetySet package combining Capnostream capnography with ventilators sold by IMI is a pioneering strategy that will provide added safety for patients in hospitals throughout Japan. Oridion is committed to improve the standard of healthcare worldwide and will continue to offer new ways to improve patient safety and make a clinical difference in patient care.”
Oridion Systems Ltd. is a global medical device company specializing in patient safety monitoring. The company operates through wholly owned subsidiaries in the United States and Israel. Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient’s breath.